Love this investment! Endonovo Therapeutics se
Post# of 416
Endonovo Therapeutics seems to be setting its self up for a run to PLSE levels. It recently announced a financing from a strategic healthcare investor to uplist its common stock onto a national stock exchange and is up more than 230% over the last three months from its all time low. ENDV's management seems to be extremely bullish on the company; having filed 48 SEC Insider Form 4 statements since late February. To quote one of the greatest investors of all time, Peter Lynch, "insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." With a market cap differential of about $300 million between ENDV and PLSE, savvy investors may want to take a closer look at Endonovo Therapeutics.
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.